Privireal Home Page Privacy in Research, Ethics and Law
"examining the implementation of the Data Protection Directive 95/46/EC
in relation to medical research and the role of ethics committees"

Austria - RECs and Medical Research

History

The system for ethical review was initiated in the early 1980's by 3 medical faculties - Vienna, Graz and Innsbruck - and was originally voluntary. These committees began to be formalised in 1988, and further laws amended and extended their roles until 1997 when an amendment to the Act on University Organization provided regulations for RECs

The Federal Act on University Organization stipulates that RECs have to be established to review 'applied medical research on humans'. Ethical review of medical research on humans that does not involve drugs, medical devices, or the application of a new medical method is mandatory only in university settings.

A Federal order of June, 2001, established a bioethics commission to advise on all social, natural scientific and legal issues arising from the scientific developments in human medicine and human biology from an ethical standpoint.

Summary of Austrian RECs

Type of REC University Hospital For studies outside hospital
Where situated? Medical Faculty Hospital
Who applies to them? researchers researchers researchers
Formal/Informal Formal - regulated by law Formal - regulated by law
Voluntary where research doesn't involve drugs, medical devices or the application of a new medical method
Formal - regulated by law
Voluntary where research doesn't involve drugs, medical devices or the application of a new medical method
National/Regional Regional Regional National
Laws Involved (see below)

Federal Act on University Organization

Federal state law
Federal Act on Hospitals
Federal state law
Guidance Involved

Declaration of Helsinki
EC-GCP Guidelines
ICH-GCP Guidelines

Declaration of Helsinki
EC-GCP Guidelines
ICH-GCP Guidelines

Declaration of Helsinki
EC-GCP Guidelines
ICH-GCP Guidelines
Membership requirements

A medical doctor (not investigator)
A medical specialist (for the subject of the applied project)
A nurse
A lawyer
A pharmacist
A patient advocate
A representative of handicapped people
A theologian (or person with pastoral/ethical competence)
A statistician/biometrician

In the case of research on medical devices:
A biomedical engineer

A medical doctor (not investigator or director of hospital)
A medical specialist (for the subject of the applied project)
A nurse
A lawyer
A pharmacist
A patient advocate
A representative of handicapped people
A theologian (or person with pastoral/ethical competence)
A statistician/ biometrician

In the case of research on medical devices:
A biomedical engineer

A medical doctor (not investigator)
A medical specialist (for the subject of the applied project)
A nurse
A lawyer
A pharmacist
A patient advocate
A representative of handicapped people
A theologian (or person with pastoral/ ethical competence)
A statistician/ biometrician

In the case of research on medical devices:
A biomedical engineer

Responsible/accountable to whom? To the medical faculty To the body responsible for the hospital To the government of the respective federal state
Approval or Advisory powers Advisory Advisory & medical director can overrule Advisory

Not submitting research or failing to follow review

Primary discipline action by hospital or university.

Which body, if not the REC itself takes this action, and how do they proceed?

As above, and if failures are brought to the public's attention, the medical association, Federal government and /or the Courts may also take action

Impact of Directive 2001/20 EC

The Directive will impact only for studies on medicinal products: a favourable opinion of the REC will be necessary for the start of a trial, a unique opinion will have to be provided for multicentre trials, only a single request for additional information will be possible & the paperwork will be enhanced. There will also be a reduction in the time limit for the evaluation of amendments.

Legal action that can be taken against RECs

The REC may be liable in case of an injury of a trial subject when it has approved patient information.
At present no action can be taken against a negative decision

Links section

See the REC bibliography section for more links and papers, and the Data Protection Page